Why Don't Brain Tumors Respond To Medication?
Tuesday, September 1, 2009 - 20:14
in Health & Medicine
Malignant brain tumors often fail to respond to promising new medication. Researchers in Germany have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.